Mackay Shields’s NYLIM US Large Cap R&D Leaders ETF LRND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-190,000
Closed -$4.78M – 509
2022
Q1
$4.78M Buy
+190,000
New +$4.63M 0.04% 364

Other funds holding LRND

Mackay Shields's LRND Position: Q2 2022 in Review

Mackay Shields sold out of NYLIM US Large Cap R&D Leaders ETF (LRND) in Q2 2022, closing a stake of 190,000 shares — an estimated $4.78M sold.

Mackay Shields first reported a position in LRND in Q1 2022 and held it in 1 quarter. The position peaked at $4.78M in Q1 2022. 1 fund tracked by Wall St. Rank holds LRND as of Q2 2022.

  • Mackay Shields reported no remaining NYLIM US Large Cap R&D Leaders ETF position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields sold 190,000 NYLIM US Large Cap R&D Leaders ETF shares in Q2 2022, an estimated $4.78M.
  • Mackay Shields first reported a position in NYLIM US Large Cap R&D Leaders ETF in Q1 2022 and held it in 1 quarter.
  • Mackay Shields's NYLIM US Large Cap R&D Leaders ETF position peaked at $4.78M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held NYLIM US Large Cap R&D Leaders ETF as of Q2 2022.

Based on Mackay Shields's 13F filing for Q2 2022, filed 3 Aug 2022.